Hereditary Amyloidosis Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Hereditary Amyloidosis Market is segmented By Drug Type (RNA Interference (RNAi) Therapeutics, Antis...

Hereditary Amyloidosis Market Size

Market Size in USD Bn

CAGR12.00%

Study Period2025-2032
Base Year of Estimation2024
CAGR12.00%
Market ConcentrationHigh
Major PlayersAlnylam Pharmaceuticals, Pfizer Inc., Ionis Pharmaceuticals, Akcea Therapeutics, Prothena Corporation and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Hereditary Amyloidosis Market Analysis

The hereditary amyloidosis market is estimated to be valued at USD 1.38 Bn in 2025 and is expected to reach USD 3.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.00% from 2025 to 2032. The increasing prevalence of hereditary amyloidosis around the world along with growing awareness regarding the disease and its treatment options among the patients are fueling the market growth.

Hereditary Amyloidosis Market Report Snapshots